Study Evaluating Intravenous Progesterone Formulation BHR-100 to Treat Traumatic Brain Injury Set to Complete in 2013 BHR Pharma's SyNAPSe® clinical trial is now enrolling patients suffering from severe traumatic brain injury (TBI) at 14 sites in Thailand, China and Russia. The trial currently has 153 participating sites (Level 1 and 2 trauma centers) worldwide. The 500th of 1,180 patients needed to complete the global Phase III, multi-center trial was enrolled at the end of May in the United States. SyNAPSe is evaluating the effectiveness of BHR-100, a... --snip-- TBI is a serious public health problem that affects more than 1.7...